comparemela.com

Latest Breaking News On - Md rutgers biomedical health sciences - Page 1 : comparemela.com

Top Coronary Artery Disease News of 2023

(SPOILER ALERT) ORBITA-2 and Ozempic were big in 2023, but other studies will also help inform clinical practice, says Sanjit Jolly.

United statesSanjit jollyWegovy ozempicJeffrey carsonEuropean society of cardiologyAmerican heart associationNovo nordiskEuropean association for cardioMd mcmaster university population health research instituteMd rutgers biomedical health sciencesAmerican college of cardiologyPopulation health research instituteEuropean societyEuropean associationCardio thoracic surgeryAmerican college

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

(UPDATED) The primary endpoint was missed in MINT, but most study findings suggest a restrictive transfusion strategy has little to add.

New yorkUnited statesNew zealandJeffrey carsonMd rutgers biomedical health sciencesPresbyterian columbia university irving medical centerAmerican heart associationRutgers biomedical health sciencesNew brunswickNew england journalMartin leonColumbia university irving medical centerReflecting real world

vimarsana © 2020. All Rights Reserved.